Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs NewSelf

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and NewSelf head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 64 · Grade C

NewSelf

Visit NewSelf Full brief →

FDA warning letter, February 2026 — issued to NewSelf Limited dba NewSelf. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 78 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make NewSelf a bad call — it's best for readers who can obtain a written three-month quote and understand the cancellation fees before choosing an installment option. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
85
Transparency
90
88
Access Breadth
93
84
Clinical Oversight
92
89
Track Record
88
65
CoreAge RxBrief Score 94 · 78NewSelf

Price, coverage & the tracker

CoreAge RxNewSelf
Brief Score94/100 (A)78/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm current price

Earlier listing: From $100/mo (compounded) (checked July 2026).

Confirm the medication, billing term and full charge before paying.

Full price details

Compounded semaglutide offered. Current medication quote unknown; earlier listing: From $100/mo (compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm current price

Earlier listing: From $144/mo (compounded) (checked July 2026).

Confirm the medication, billing term and full charge before paying.

Full price details

Compounded tirzepatide offered. Current medication quote unknown; earlier listing: From $144/mo (compounded)

CoverageUS only; restrictions by state, confirmed at intake49 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

NewSelf: Earlier prices remain historical. Current pages show conflicting medication quotes; obtain the full three-month charge, installment schedule and applicable early cancellation fee before paying.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.